Bank of America
RANI icon

Bank of America’s Rani Therapeutics RANI Stock Holding History

Bank of America’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-36,607
Closed -$49.4K – 6635
2025
Q4 		$49.4K Buy
36,607
+18,855
+106% +$28.4K ﹤0.01% 5847
2025
Q3 		$8.86K Sell
17,752
-13,413
-43% -$6.99K ﹤0.01% 7216
2025
Q2 		$16K Sell
31,165
-15,475
-33% -$12.6K ﹤0.01% 7099
2025
Q1 		$58.8K Sell
46,640
-27,488
-37% -$40.7K ﹤0.01% 6697
2024
Q4 		$102K Sell
74,128
-2,017
-3% -$4.24K ﹤0.01% 6392
2024
Q3 		$164K Sell
76,145
-15,701
-17% -$45K ﹤0.01% 6104
2024
Q2 		$349K Sell
91,846
-32,659
-26% -$169K ﹤0.01% 5562
2024
Q1 		$387K Buy
124,505
+10,246
+9% +$35.2K ﹤0.01% 5494
2023
Q4 		$379K Sell
114,259
-92,862
-45% -$215K ﹤0.01% 5692
2023
Q3 		$450K Buy
207,121
+34,831
+20% +$133K ﹤0.01% 5385
2023
Q2 		$710K Buy
172,290
+158,839
+1,181% +$737K ﹤0.01% 5020
2023
Q1 		$69.4K Buy
13,451
+9,618
+251% +$57.8K ﹤0.01% 6388
2022
Q4 		$22.6K Buy
3,833
+1,110
+41% +$8.1K ﹤0.01% 6697
2022
Q3 		$27K Buy
2,723
+578
+27% +$6.13K ﹤0.01% 6925
2022
Q2 		$22K Sell
2,145
-1,010
-32% -$11.6K ﹤0.01% 7159
2022
Q1 		$42K Sell
3,155
-1,267
-29% -$21K ﹤0.01% 7248
2021
Q4 		$73K Buy
4,422
+2,955
+201% +$67.2K ﹤0.01% 7030
2021
Q3 		$26K Buy
+1,467
New +$25.4K ﹤0.01% 7311

Other funds holding RANI

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCP
SymBiosis Capital Partners Bentonville, Arkansas $52.8M AUM
LP
Longaeva Partners Chicago, Illinois $2.7B AUM 37.16% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return

Bank of America's RANI Position: Q1 2026 in Review

Bank of America sold out of Rani Therapeutics (RANI) in Q1 2026, closing a stake of 36,607 shares — an estimated $49.4K sold.

Bank of America first reported a position in RANI in Q3 2021 and held it in 18 quarters. The position peaked at $710K in Q2 2023. 74 funds tracked by Wall St. Rank hold RANI as of Q1 2026.

  • Bank of America reported no remaining Rani Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 36,607 Rani Therapeutics shares in Q1 2026, an estimated $49.4K.
  • Bank of America first reported a position in Rani Therapeutics in Q3 2021 and held it in 18 quarters.
  • Bank of America's Rani Therapeutics position peaked at $710K in Q2 2023.
  • 74 funds tracked by Wall St. Rank held Rani Therapeutics as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.